Yariv Houvras

Direttore Tecnico/Scientifico/R&S presso XILIO THERAPEUTICS, INC.

Consumer Services

Health Technology

Profilo

Dr. Yariv J.
Houvras is a Chief Medical Officer at Xilio Therapeutics, Inc. Dr. Houvras was previously employed as a SVP-Clinical & Translational Development by Tubulis GmbH.
He received his undergraduate degree from the University of Michigan and a doctorate degree from Icahn School of Medicine at Mount Sinai.

Posizioni attive di Yariv Houvras

Società	Posizione	Inizio
XILIO THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	28/09/2026

Tutte le posizioni attive di Yariv Houvras

Precedenti posizioni note di Yariv Houvras

Società	Posizione	Fine
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Yariv Houvras

Formazione di Yariv Houvras

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Yariv Houvras

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Health Technology